Literature DB >> 17035942

The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis.

J J T H Roelofs1, K M A Rouschop, G J D Teske, N Claessen, J J Weening, T van der Poll, S Florquin.   

Abstract

The urokinase plasminogen activator receptor (uPAR) is expressed at the cell surface of inflammatory cells and plays an important role in neutrophil migration. To investigate the in vivo role of uPAR during urinary tract infection, acute pyelonephritis was induced in uPAR-/- and wild-type (WT) mice by intravesical inoculation with 1 x 10(9) colony-forming units (CFU) of uropathogenic Escherichia coli. Mice were killed after 24 and 48 h, after which bacterial outgrowth and cytokine levels in kidney homogenates were determined. Influx of neutrophils was quantified by myeloperoxidase-enzyme-linked immunosorbent assay. uPAR-/- kidneys had significantly higher numbers of E. coli CFU, accompanied by higher levels of interleukin-1beta (IL-1beta), IL-6, keratinocyte-derived chemokine (KC), macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor-alpha (TNF-alpha). However, the number of infiltrating neutrophils was similar in uPAR-/- and WT mice at both time points, suggesting that uPAR-/- neutrophils have a lower ability to eliminate E. coli. To further investigate this, neutrophil oxidative burst and phagocytosis was measured. The generation of reactive oxygen species upon stimulation with E. coli was not diminished in uPAR-/- neutrophils compared with WT. Interestingly, uPAR-/- neutrophils displayed significantly impaired phagocytosis of E. coli organisms compared with WT neutrophils. We conclude that uPAR is crucially involved in host defense through phagocytosis during E. coli induced acute pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035942     DOI: 10.1038/sj.ki.5001947

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  S100A8/A9 is not involved in host defense against murine urinary tract infection.

Authors:  Mark C Dessing; Loes M Butter; Gwendoline J Teske; Nike Claessen; Chris M van der Loos; Thomas Vogl; Johannes Roth; Tom van der Poll; Sandrine Florquin; Jaklien C Leemans
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

Review 2.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 3.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

4.  G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.

Authors:  Molly A Ingersoll; Kimberly A Kline; Hailyn V Nielsen; Scott J Hultgren
Journal:  Cell Microbiol       Date:  2008-08-26       Impact factor: 3.715

Review 5.  Serum suPAR in patients with FSGS: trash or treasure?

Authors:  Rutger J H Maas; Jeroen K J Deegens; Jack F M Wetzels
Journal:  Pediatr Nephrol       Date:  2013-03-21       Impact factor: 3.714

6.  Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection.

Authors:  Per Wittenhagen; Jesper Brandt Andersen; Anita Hansen; Lone Lindholm; Frederik Rønne; Jørn Theil; Michael Tvede; Jesper Eugen-Olsen
Journal:  Biomark Insights       Date:  2011-08-16

7.  The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

Authors:  Joppe W R Hovius; Maarten F Bijlsma; Gerritje J W van der Windt; W Joost Wiersinga; Bastiaan J D Boukens; Jeroen Coumou; Anneke Oei; Regina de Beer; Alex F de Vos; Cornelis van 't Veer; Alje P van Dam; Penghua Wang; Erol Fikrig; Marcel M Levi; Joris J T H Roelofs; Tom van der Poll
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

8.  Urokinase gene 3'-UTR T/C polymorphism is associated with malignancy and ESRD in idiopathic membranous nephropathy.

Authors:  Cheng-Hsu Chen; Shih-Yin Chen; Kuo-Hsiung Shu; Mei-Chin Wen; Chi-Hung Cheng; Ming-Ju Wu; Tung-Min Yu; Ya-Wen Chuang; Fuu-Jen Tsai
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

9.  Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.

Authors:  Diba Emal; Elena Rampanelli; Nike Claessen; Frederike J Bemelman; Jaklien C Leemans; Sandrine Florquin; Mark C Dessing
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.